Trial intelligence / Profile preview

Comparison of intravenous dexmedetomidine versus labetalol on blood loss during endoscopic sinus surgery

TCTR20160404003Phase 2Completed

Sponsor
Shahid Sadoughi University of Medical Sciences
Start
Jul 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of dexmedetomidine, labetalol in chronic rhinosinusitis (CRS), sponsored by Shahid Sadoughi University of Medical Sciences. Started Jul 2014; status: completed.

02

Drugs

dexmedetomidinelabetalol
03

Conditions

chronic rhinosinusitis (CRS)

Beyond the preview

Go deeper on TCTR20160404003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20160404003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call